🚀 VC round data is live in beta, check it out!
Terveystalo Valuation Multiples
Discover revenue and EBITDA valuation multiples for Terveystalo and similar public comparables like Dr. Sulaiman Al Habib Medical Services, Netcare, Ramsay Santé, Thomson Medical and more.
Terveystalo Overview
About Terveystalo
Terveystalo PLC o is a healthcare service provider in Finland. The company offers primary and specialized healthcare services to corporate, private, and public sector customers. Its healthcare service offering includes general practice and specialist medical care, diagnostic services, outpatient surgery, dental services and other adjacent services; it covers the entire integrated treatment chain of healthcare. The Group comprises of three reporting segments: Healthcare Services, Portfolio Businesses, and Sweden, out of which it derives maximum revenue from Healthcare Services segment.
Founded
2001
HQ
Employees
9.2K
Website
Sectors
Financials (LTM)
EV
$2B
Terveystalo Financials
Terveystalo reported last 12-month revenue of $2B and EBITDA of $290M.
In the same LTM period, Terveystalo generated $905M in gross profit, $290M in EBITDA, and $112M in net income.
Revenue (LTM)
Terveystalo P&L
In the most recent fiscal year, Terveystalo reported revenue of $2B and EBITDA of $294M.
Terveystalo expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Profit | $905M | XXX | $906M | XXX | XXX | XXX |
| Gross Margin | 60% | XXX | 60% | XXX | XXX | XXX |
| EBITDA | $290M | XXX | $294M | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | 19% | XXX | XXX | XXX |
| EBIT Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| Net Profit | $112M | XXX | $110M | XXX | XXX | XXX |
| Net Margin | 7% | XXX | 7% | XXX | XXX | XXX |
| Net Debt | — | — | $360M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Terveystalo Stock Performance
Terveystalo has current market cap of $1B, and enterprise value of $2B.
Market Cap Evolution
Terveystalo's stock price is $10.07.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $1B | -4.9% | XXX | XXX | XXX | $0.87 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTerveystalo Valuation Multiples
Terveystalo trades at 1.2x EV/Revenue multiple, and 6.5x EV/EBITDA.
EV / Revenue (LTM)
Terveystalo Financial Valuation Multiples
As of April 18, 2026, Terveystalo has market cap of $1B and EV of $2B.
Equity research analysts estimate Terveystalo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Terveystalo has a P/E ratio of 11.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | 1.2x | XXX | XXX | XXX |
| EV/EBITDA | 6.5x | XXX | 6.4x | XXX | XXX | XXX |
| EV/EBIT | 10.3x | XXX | 10.1x | XXX | XXX | XXX |
| EV/Gross Profit | 2.1x | XXX | 2.1x | XXX | XXX | XXX |
| P/E | 11.4x | XXX | 11.6x | XXX | XXX | XXX |
| EV/FCF | 14.2x | XXX | 10.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Terveystalo Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Terveystalo Margins & Growth Rates
Terveystalo's revenue in the last 12 month declined by (1%).
Terveystalo's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Terveystalo's rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Terveystalo's rule of X is 16% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Terveystalo Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | (1%) | XXX | (2%) | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | (1%) | XXX | (4%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 18% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 16% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 0% | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 49% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Terveystalo Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Terveystalo | XXX | XXX | XXX | XXX | XXX | XXX |
| Dr. Sulaiman Al Habib Medical Services | XXX | XXX | XXX | XXX | XXX | XXX |
| Netcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Santé | XXX | XXX | XXX | XXX | XXX | XXX |
| Thomson Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| U.S. Physical Therapy | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Terveystalo M&A Activity
Terveystalo acquired XXX companies to date.
Last acquisition by Terveystalo was on XXXXXXXX, XXXXX. Terveystalo acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Terveystalo
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialTerveystalo Investment Activity
Terveystalo invested in XXX companies to date.
Terveystalo made its latest investment on XXXXXXXX, XXXXX. Terveystalo invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Terveystalo
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Terveystalo
| When was Terveystalo founded? | Terveystalo was founded in 2001. |
| Where is Terveystalo headquartered? | Terveystalo is headquartered in Finland. |
| How many employees does Terveystalo have? | As of today, Terveystalo has over 9K employees. |
| Who is the CEO of Terveystalo? | Terveystalo's CEO is Ville Iho. |
| Is Terveystalo publicly listed? | Yes, Terveystalo is a public company listed on Nasdaq Helsinki. |
| What is the stock symbol of Terveystalo? | Terveystalo trades under TTALO ticker. |
| When did Terveystalo go public? | Terveystalo went public in 2017. |
| Who are competitors of Terveystalo? | Terveystalo main competitors are Dr. Sulaiman Al Habib Medical Services, Netcare, Ramsay Santé, Thomson Medical. |
| What is the current market cap of Terveystalo? | Terveystalo's current market cap is $1B. |
| What is the current revenue of Terveystalo? | Terveystalo's last 12 months revenue is $2B. |
| What is the current revenue growth of Terveystalo? | Terveystalo revenue growth (NTM/LTM) is (1%). |
| What is the current EV/Revenue multiple of Terveystalo? | Current revenue multiple of Terveystalo is 1.2x. |
| Is Terveystalo profitable? | Yes, Terveystalo is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Terveystalo? | Terveystalo's last 12 months EBITDA is $290M. |
| What is Terveystalo's EBITDA margin? | Terveystalo's last 12 months EBITDA margin is 19%. |
| What is the current EV/EBITDA multiple of Terveystalo? | Current EBITDA multiple of Terveystalo is 6.5x. |
| What is the current FCF of Terveystalo? | Terveystalo's last 12 months FCF is $132M. |
| What is Terveystalo's FCF margin? | Terveystalo's last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of Terveystalo? | Current FCF multiple of Terveystalo is 14.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.